missing translation for 'onlineSavingsMsg'
Learn More

CCL3L1/LD78 beta Antibody - BSA Free, Novus Biologicals™

Rabbit Polyclonal Antibody

Brand:  Novus Biologicals NBP3-05563-20ul

 View more versions of this product

Product Code. 18663387

  • £149.00 / 20µL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

CCL3L1/LD78 beta Polyclonal antibody specifically detects CCL3L1/LD78 beta in Human samples. It is validated for Western Blot
TRUSTED_SUSTAINABILITY
Specifications

Specifications

CCL3L1/LD78 beta
Polyclonal
Western Blot 1:500-1:2000
C-C motif chemokine 3-like 1, CCL3L3, chemokine (C-C motif) ligand 3-like 1, D17S1718, G0/G1 switch regulatory protein 19-2, G0S19-2LD78, LD78BETA, LD78-beta(1-70), MGC104178, MGC12815, MGC182017, MIP1AP, PAT 464.2, SCYA3L, SCYA3L1464.2, small inducible cytokine A3-like 1, Small-inducible cytokine A3-like 1, Tonsillar lymphocyte LD78 beta protein
Recombinant fusion protein containing a sequence corresponding to amino acids 24-93 of human CCL3L1/LD78 beta (NP_066286.1). APLAADTPTACCFSYTSRQIPQNFIADYFETSSQCSKPSVIFLTKRGRQVCADPSEEWVQKYVSDLELSA
20 μg
Cell Cycle and Replication, Cytokine Research
6349
Store at -20°C. Avoid freeze-thaw cycles.
IgG
Western Blot
Unconjugated
PBS with 50% glycerol, pH7.3.
Rabbit
Affinity purified
RUO
Primary
Human
Purified
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.